Help prevent BRD with effective vaccines

Preventing BRD is generally far more cost-effective than treating the disease. Using vaccines that deliver effective levels of protection can help boost cattle immune response to disease-causing respiratory pathogens. You can trust the respiratory vaccine portfolio from Zoetis because it’s backed by decades of research and combines innovative products with advanced immunization strategies.

INFORCE 3 and ONE SHOT BVD product shots

For example, the concurrent use of INFORCE 3® and ONE SHOT® BVD delivers fast, comprehensive respiratory protection, which helps get calves off to a healthy start:

  • Intranasal INFORCE 3 stimulates lasting, protective immunity where infectious bovine rhinotracheitis (IBR), bovine respiratory syncytial virus (BRSV) and parainfluenza 3 (PI3) respiratory diseases start. 1
  • ONE SHOT BVD provides effective protection against respiratory diseases caused by Mannheimia haemolytica and bovine viral diarrhea (BVD) Types 1 and 2 viruses. 1

BOVI-SHIELD GOLD ONE SHOT® offers comprehensive calf protection that is convenient:

  • Helps prevent respiratory disease caused by IBR virus and viremia from BVD Types 1 and 2 viruses
  • Protects against respiratory disease caused by BVD Types 1 and 2 viruses, BRSV, PI3 virus and bovine pneumonia caused by M. haemolytica

Support Animal Health with Feed Additives

Choose from effective feed additives to provide an extra level of protection, especially in high-risk animals:

  • Aureomycin with logo

    AUREOMYCIN® broad-spectrum respiratory and enteric disease control.*

    On arrival and throughout the feeding period, AUREOMYCIN helps manage diseases that can negatively impact performance.

  • Aureo S 700 with logo

    AUREO S 700® maintains weight gain during high-stress periods.*

    Cattle fed AUREO S 700 during the first 28 days on feed had lower morbidity, chronics and mortality than nonmedicated controls. 2

  • Deccox with logo

    DECCOX® prevents coccidiosis that’s common in newly arrived cattle.

    It can reduce treatment costs and performance losses associated with clinical outbreaks later in the feeding period.

From first use to finish: three proven antimicrobials

Even with good management and well-planned vaccination programs, BRD can’t always be prevented. When this happens, work with your veterinarian to select the right antimicrobials to optimize herd health and deliver your best return on investment. Zoetis offers three proven products with different durations of activity, withdrawal periods and modes of action so you can customize a BRD program to your needs. These products are backed by outcomes-based research that demonstrates greater efficacy in controlling and treating BRD when compared with other antibiotics — so you’re more likely to knock out BRD in the first round.

  • Draxxin with logo

    DRAXXIN®: Other treatments were 50% as effective in studies. 34

    DRAXXIN (tulathromycin injection) Injectable Solution demonstrated 50% fewer re-treats and 50% fewer dead or chronic animals 3 versus competitive products in several large pen studies. 4

  • Excede with logo

    EXCEDE® offers up to seven days of therapy in one dose.

    EXCEDE (ceftiofur crystalline free acid) Sterile Suspension delivers proven efficacy with seven days of BRD therapy and a unique route of administration to reduce trim loss.

  • Advocin with logo

    ADVOCIN® provides a short, four-day withdrawal.

    With a four-day withdrawal, ADVOCIN (danofloxacin injection) Sterile Antimicrobial Injectable Solution makes it easy to treat market-ready cattle.

Which antimicrobial fits for your operation?

See how Zoetis antimicrobials stack up against other products.

Zoetis representative discussing product details with 2 guys

Technical support

You can count on Zoetis for industry-leading technical expertise including:

  • Local representative support
  • ROI-driven outcomes data
  • Beef Technical Services
  • Veterinary Medical Information and Product Support (VMIPS)

To place an order for a Zoetis product, ask a question about your account or our products and services, please contact Zoetis Customer Service at 888-ZOETIS-1 or 888-963-8471.

To support your responsible use of antibiotics and help ensure these medications remain effective and available, we:

  • Advocate for animals and the people who care for them
  • Innovate to deliver new solutions
  • Collaborate with producers and veterinarians as well as those in industry, government and the food chain
Important Safety Information

DRAXXIN: DRAXXIN has a pre-slaughter withdrawal time of 18 days. Do not use in female dairy cattle 20 months of age or older. Do not use in animals known to be hypersensitive to the product. Full Prescribing Information

EXCEDE: People with known hypersensitivity to penicillin or cephalosporins should avoid exposure to EXCEDE. EXCEDE is contraindicated in animals with known allergy to ceftiofur or to the ß-lactam group (penicillins and cephalosporins) of antimicrobials. Inadvertent intra-arterial injection is possible and fatal. Do not use in calves to be processed for veal. Pre-slaughter withdrawal time is 13 days following the last dose. Full Prescribing Information

ADVOCIN: Extra-label use of ADVOCIN in food-producing animals is prohibited. Do not use in cattle intended for dairy production or in calves to be processed for veal. ADVOCIN has a pre-slaughter withdrawal time of four days. Full Prescribing Information

AUREOMYCIN: Do not use AUREOMYCIN in calves to be processed for veal.

AUREO S 700: Withdraw AUREO S 700 seven (7) days prior to slaughter. Do not use in calves to be processed for veal.

DECCOX: Do not use DECCOX in cows producing milk for human consumption.

  1. Data on file, Study Report No. 3131W-60-11-843, Zoetis Inc. 
  2. Gallo GV, Berg JL. Efficacy of a feed additive antibacterial combination for improving feedlot cattle performance and health. Can Vet J. 1995;36(4):223-229. 
  3. Data on file, Study Report Nos. 1133R-60-05-491, A131R-US-12-028, 2132T-60-01-050, 1133R-60-02-376, 2132T-60-01-063, 1133R-60-03-388 and 11RGDRA01, Zoetis Inc. 
  4. Data on file, Study Report Nos. 1133R-60-05-491, 1133R-60-05-492, 1133R-60-05-493, A131R-US-12-028, 2132T-60-01-050, 1133R-60-02-376, 2132T-60-01-063 and 1133R-60-03-388, Zoetis Inc.